Galderma Achieves FDA Approval of AKLIEF® (trifarotene)
In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…
Certara2020 年 11 月 9 日
Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
As of 2020 年 7 月 28 日, 1840 clinical trials were registered globally, with 1001 clinical trials…
Certara2020 年 8 月 22 日
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…
Certara2020 年 8 月 22 日
Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm
Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…
Certara2020 年 7 月 26 日
The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development
3 key tips to set your pediatric program up for success with the RACE for…
Certara2020 年 7 月 14 日
Mechanistic quantitative pharmacology strategies for the early clinical development of bispecific antibodies in oncology
Bispecific antibodies (bsAbs) have become an integral component of the therapeutic research strategy to treat…
Certara2020 年 7 月 14 日
Local Therapies for the Global COVID-19 Pandemic
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…
Certara2020 年 5 月 29 日
Applying decision analysis to drug development for COVID-19 & future pandemics
This blog discusses how decision analysis approaches can help drug developers to better decisions under…
Certara2020 年 4 月 30 日
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and…
Certara2020 年 2 月 19 日
